Literature DB >> 24755018

Validation of the Spanish version of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST).

Gabriel Rubio Valldolid1, José Martínez-Raga, Isabel Martínez-Gras, Guillermo Ponce Alfaro, Javier de la Cruz Bértolo, Rosa Jurado Barba, Alina Rigabert Sánchez-Junco, José Zarco Montejo.   

Abstract

BACKGROUND: To evaluate the psychometric properties of the Spanish version of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and its effectiveness as a screening tool for problematic alcohol, tobacco and other psychoactive substance use in groups of low, moderate, and high risk users.
METHODS: A test battery including the ASSIST and several standardized screening, assessment, and diagnostic instruments was administered to 485 patients recruited in different primary health-care facilities and specialized addiction treatment units from Health Area 11 in Madrid.
RESULTS: ASSIST cut-off scores show a good sensitivity and specificity for discrimination between substance use and abuse and between abuse and dependence. Concurrent validity was demonstrated by significant correlations between ASSIST scores and scores from the Mini-International Neuropsychiatric Interview (MINI-Plus), the Alcohol Use Disorders Identification Test (AUDIT), the Revised Fagerstrom Tolerance Questionnaire (RTQ) and the Severity of Dependence Scale (SDS).
CONCLUSIONS: Psychometric properties of the Spanish version of the ASSIST indicate that is a valid screening test for identifying substance use disorders in various health-care settings.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24755018     DOI: 10.7334/psicothema2013.172

Source DB:  PubMed          Journal:  Psicothema        ISSN: 0214-9915


  7 in total

1.  Validation of a substance and alcohol use assessment instrument among orphans and vulnerable children in Zambia using Audio Computer Assisted Self-Interviewing (ACASI).

Authors:  Jeremy C Kane; Laura K Murray; Judith K Bass; Renee M Johnson; Paul Bolton
Journal:  Drug Alcohol Depend       Date:  2016-06-29       Impact factor: 4.492

2.  Prevalence of Depression and Associated Factors Among Normal and Overweight Reproductive Age Women, Ethiopia: Community-Based Comparative Cross-Sectional Study.

Authors:  Abayneh Shewangzaw Engda; Habte Belete; Fikir Addisu Tilahun; Solomon Moges Demeke; Nigus Alemnew Engidaw; Abate Dargie Wubetu; Eyosiyas Yeshialem Asefa
Journal:  Int J Womens Health       Date:  2021-03-22

Review 3.  Brief Mental Health Disorder Screening Questionnaires and Use with Public Safety Personnel: A Review.

Authors:  Robyn E Shields; Stephanie Korol; R Nicholas Carleton; Megan McElheran; Andrea M Stelnicki; Dianne Groll; Gregory S Anderson
Journal:  Int J Environ Res Public Health       Date:  2021-04-03       Impact factor: 3.390

4.  Intimate partner violence and COVID-19 among reproductive age women: A community-based cross-sectional survey, Ethiopia.

Authors:  Abayneh Shewangzaw Engda; Abate Dargie Wubetu; Fetene Kasahun Amogne; Tebabere Moltot Kitaw
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

5.  Magnitude and determinants of suicide among overweight reproductive-age women, Chacha and Debre Berhan Town, Ethiopia: community based cross-sectional study.

Authors:  Abayneh Shewangzaw Engda; Habte Belete; Abate Dargie Wubetu; Nigus Alemnew Engidaw; Fetene Kasahun Amogne; Tebabere Moltot Kitaw; Tilahun Bete; Worku Misganaw Kebede; Bantalem Tilaye Atinafu; Solomon Moges Demeke
Journal:  Int J Ment Health Syst       Date:  2022-08-16

6.  Web-Based Alcohol, Smoking, and Substance Involvement Screening Test Results for the General Spanish Population: Cross-Sectional Study.

Authors:  Juan A Lopez-Rodriguez; Gabriel Rubio Valladolid
Journal:  J Med Internet Res       Date:  2018-02-16       Impact factor: 5.428

7.  [Drug using risks screening in primary care patients using the ASSIST test: Cross sectional study].

Authors:  Juan A López-Rodríguez; Alina Rigabert; M Nieves Gómez Llano; Gabriel Rubio
Journal:  Aten Primaria       Date:  2018-03-15       Impact factor: 1.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.